Cargando…
Whole-genome sequencing of clarithromycin resistant Helicobacter pylori characterizes unidentified variants of multidrug resistant efflux pump genes
BACKGROUND: Clarithromycin (CLR) is the key drug in eradication therapy of Helicobacter pylori (H. pylori) infection, and widespread use of CLR has led to an increase in primary CLR-resistant H. pylori. The known mechanism of CLR resistance has been established in A2146G and A2147G mutations in the...
Autores principales: | Iwamoto, Akira, Tanahashi, Toshihito, Okada, Rina, Yoshida, Yukio, Kikuchi, Kaoru, Keida, Yoshihide, Murakami, Yoshiki, Yang, Lin, Yamamoto, Koji, Nishiumi, Shin, Yoshida, Masaru, Azuma, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079918/ https://www.ncbi.nlm.nih.gov/pubmed/24995043 http://dx.doi.org/10.1186/1757-4749-6-27 |
Ejemplares similares
-
Genetic variants of Helicobacter pylori type IV secretion system components CagL and CagI and their association with clinical outcomes
por: Ogawa, Hirofumi, et al.
Publicado: (2017) -
The Contribution of Efflux Pumps in Mycobacterium abscessus Complex Resistance to Clarithromycin
por: Vianna, Júlia S., et al.
Publicado: (2019) -
Efflux Pumps Contribute to Intrinsic Clarithromycin Resistance in Clinical, Mycobacterium abscessus Isolates
por: Guo, Qi, et al.
Publicado: (2020) -
Efflux Pump-Mediated Resistance in Chemotherapy
por: Ughachukwu, PO, et al.
Publicado: (2012) -
Efflux pump proteins in antifungal resistance
por: Prasad, Rajendra, et al.
Publicado: (2014)